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The ecto-5’-nucleotidase (ecto-5’NT/CD73) represents a crucial enzyme for endogenous 
adenosine generation. Several findings have shown that CD73 plays an important 
role in regulating vascular permeability and immune cell function. Adenosine 5’-(α,β-
methylene)diphosphate (APCP) is a CD73 inhibitor, widely used as pharmacological tool 
to investigate the role of CD73/adenosine pathway in several in vitro and in vivo models, 
although it has been also shown to inhibit other ectoenzymes involved in adenosinergic 
pathway. Here, we evaluated the effect of APCP in the development of inflammation 
in carrageenan-induced pleurisy model. We found that treatment with APCP (400 μg/
rat) significantly increased cell accumulation, exudate formation, and pro-inflammatory 
cytokine content into the pleural cavity in the acute phase (4 h) of inflammation, with 
no differences in the sub-acute phase (72 h) except for the regulation of monocyte 
chemotactic protein-1 levels. In addition, cells collected by pleural lavage fluids of APCP-
treated rats, 4 h following carrageenan injection, showed increased ability to migrate in 
vitro, both in presence and in absence of N-formyl-L-methionyl-L-leucyl-L-phenylalanine 
as chemotactic stimulus, compared to cells obtained by control rats. Our results 
demonstrate that APCP exacerbates the early phase of carrageenan-induced pleurisy 
by controlling pleural effusion and polymorphonuclear migration in vivo and ex vivo. This 
effect is likely dependent upon CD73 inhibition, although an inhibitory effect of other 
ectoenzymes cannot be ruled out.
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INTRODUCTION
Ecto-5’-nucleotidase (ecto-5’NT/CD73), the key enzyme in leading to adenosine accumulation, 
has been localized on barrier cell types, such as endothelial cells, and participates in the control of 
barrier permeability. Thompson and coworkers (2004) by performing experiments on genetically 
modified mice, lacking CD73, were the first to demonstrate the important role for this ecto-
enzyme in the control of the vascular leakage following hypoxia, a common feature of inflamed 
tissues. This finding was in agreement with previous experimental work demonstrating that 
following hypoxia the increased CD73 activity and extracellular adenosine accumulation represent 
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a protection preserving intestinal epithelium from vascular 
leakage. On the other hand, administration to mice of the CD73 
inhibitor α,β-methylene adenosine 5’-diphosphate (APCP) 
significantly increased the permeability of intestinal epithelium 
(Synnestvedt et al., 2002; Ledoux et al., 2003). Although CD73 
has been shown to play an important role in the development 
of pulmonary inflammation and protection against lung injury 
induced by artificial ventilation in mice (Eckle et al., 2007), less 
is known on changes of its expression and activity on tissues 
and cells following inflammation. Indeed, in an inflammatory 
environment, recruited and stromal cells expressing CD73 are 
critical producers of adenosine that, in turn, by engaging its 
receptors on adjacent cells, exerts an immunomodulatory effect 
(Antonioli et al., 2013).
Pleurisy is characterized by inflammation of the pleura, 
the tissue composed of mesothelial cells, lining the lung and 
regulating pleural cavity homeostasis. Carrageenan-induced rat 
pleurisy is a model characterized by an early (4 h) and late (72 h) 
phase of inflammation, and it is a useful model to study pleural 
effusion, resulting in extravasation and cell accumulation into 
the pleural space (Murai et al., 2003) that may represent a severe 
complication of pulmonary and extra pulmonary diseases.
Aim of the present study was to analyze the role of CD73 in 
pleural effusion, in rat. We found that treatment with the CD73 
inhibitor, APCP, influences the accumulation of leukocytes and 
cytokine production within pleural cavity. These effects were 
associated with worsened lung injury and enhanced ability of 
pleural leukocytes to migrate. All together, our data suggest that 
CD73 represents an endogenous modulator of pleural effusion 
during the early phase of inflammation.
MATERIALS AND METHODS
Animals
All experiments were performed on male Wistar rats (220–260 g; 
Charles River, Calco, Italy). The animals were maintained at a 
room temperature of 22 ± 2° on a 12 h/12 h light/dark cycle and 
were housed in a specific pathogen-free environment and fed 
standard rodent chow and water ad libitum. All procedures were 
performed according to the Italian (DL 26/2014) and European 
(n.63/2010/UE) regulations on the protection of animals used for 
experimental and other scientific purposes and were approved by 
Italian Ministry of Health (Number 1039/2016).
Carrageenan-Induced Pleurisy
Rats were anesthetized with 4% enflurane mixed with 0.5 L/min 
O2 and 0.5  L/min N2O, and a skin incision at the level of the left 
sixth intercostal space was performed. The underlying muscle 
was dissected, and 0.2 ml of λ-carrageenan type IV (1% w/v; 
Sigma-Aldrich, Milan, Italy) was injected into the pleural cavity. 
The CD73 inhibitor, APCP (400 μg/rat; Tocris Bioscience, Bristol, 
UK), or an equal volume of the vehicle (distilled water), was 
injected into the pleural cavity immediately before carrageenan 
injection. The skin was then sutured, and animals were returned 
to their cages and allowed to have food and water ad libitum; 
4 and 72 h following pleurisy induction, rats were sacrificed by 
CO2 inhalation. The chest was carefully opened, and the pleural 
cavity was washed with 2 ml of sterile saline containing 10 U/
ml heparin (Sigma-Aldrich, Milan Italy). Any lavage fluid with 
blood contamination was rejected. The volume of pleural lavage 
fluid collected from each animal was measured; then, fluids 
were centrifuged at 180 × g for 10 min and the pellet suspended 
in phosphate-buffered saline (PBS). Cells were counted with 
TC20™ Automated Cell Counter (Bio-Rad, Italy). Samples of 
supernatants and cell pellets were then frozen at −80°C to be 
successively analyzed for cytokine content and AMPase activity, 
whereas differential cell count was performed in smears by May-
Grunwald-Giemsa staining (Carlo Erba, Italy). Lung samples 
were harvested from each rat and immediately frozen at −80°C 
or fixed in formaldehyde solution (4% v/v, in distilled water) for 
1 week at room temperature and successively utilized for further 
analyses.
Morphological Analysis
Morphological analysis was performed on pulmonary tissue 
samples from vehicle- and APCP-treated rats. Lung biopsies 
harvested 4 or 72 h following carrageenan injection and fixed 
in formaldehyde, as described above, were dehydrated using 
graded ethanol and embedded in Paraplast (Sherwood Medical, 
Mahwah, NJ). Tissue sections (7-μm thickness) were then 
deparaffinized with xylene and stained with hematoxylin and 
eosin (Kaltek, Padova, Italy). A minimum of five sections per 
animal was analyzed under direct light microscopy (original 
magnification X 20) and photographed by a Leica DFC320 
video camera (Leica, Milan, Italy) connected to a Leica DM RB 
microscope by using the Leica Application Suite software V 4.1.0.
AMPase Activity
AMPase activity, evaluated as previously described (Caiazzo et al., 
2016), was assessed in cells, lung samples, and cell-free pleural 
lavage fluids collected from rats 4 or 72 h following pleurisy 
induction, by colorimetric measurement of the inorganic phosphate 
(Pi) released following incubation with the substrate, as described 
by Nedeljkovic et al. (2006). Cell pellets were suspended in 50 μl 
of ice-cold lysis buffer [4-[2-hydroxyethyl]-1-piperazine ethane 
sulfonic acid (HEPES), 200 mM; NaCl, 400 mM; dithiothreitol 
(DTT), 1 mM; IGEPAL, 1%; glycerol, 20% (Carlo Erba, Italy), plus 
the protease inhibitor cocktail (Roche, Italy)] and maintained in 
constant agitation for 45 min at 4°C. Lung tissue was transferred 
into a tube preloaded with one (6.35 mm) diameter zirconium 
oxide coated ceramic grinding sphere in ice-cold lysis buffer [Tris-
HCl, 50 mM pH 7.5; NaCl, 150 mM; sodium orthovanadate, 
1  mM; β glycerophosphate, 20 mM; ethylenediaminetetraacetic 
acid (EDTA), 2 mM; phenylmethylsulfonyl fluoride (PMSF), 
1  mM; leupeptin, 5 μg/ml; aprotinin, 5 μg/ml; pepstatin, 5 μg/ml; 
ICN Pharmaceuticals, Italy] and put into a FastPrep®-24 
homogenizer (MP Biomedicals, Santa Ana, California, USA) for 
lysis. Cell lysates and lung homogenates were then centrifuged for 
15 min at 8,000 × g at 4°C, and the supernatant (protein extract) 
was collected and stored at −80°C until analysis. To initiate the 
enzymatic reaction, samples (50 µg of proteins) were incubated with 
200 μl of medium containing MgCl2 (10 mM), NaCl (120 mM), 
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KCl (5 mM), glucose (60 mM), Tris-HCl (50 mM), and pH 7.4. After 
10 min, AMP (2 mM) was added as substrate and samples kept at 
37°C for 40 min. The reaction was then stopped by the addition of 
trichloroacetic acid (final concentration 5% w/v). Following sample 
centrifugation at 500 × g for 10 min, at 37°C, the release of Pi was 
measured using Malachite Green Phosphate Assay Kit (ScienCell, 
Research Laboratories, Carlsbad, USA) and KH2PO4 as standard 
(Chan et al., 1986). To have the net value of Pi produced following 
enzymatic reaction, aspecific Pi released in the absence of AMP in 
each sample was evaluated and the value obtained was subtracted 
from the value obtained following incubation with AMP. Protein 
concentration was measured by Bradford assay, and results were 
expressed as Pi released (pmol/min/µg protein). AMPase activity 
was also assessed in cell-free pleural lavage fluids collected from 
rats 4 and 72 h following pleurisy induction by performing the 
same procedure described above.
Cytokine Measurement
In the pleural lavage fluids collected 4 and 72 h following 
carrageenan injection, levels of tumor necrosis factor-α 
(TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6), and 
monocyte chemotactic protein-1 (MCP-1) were evaluated by a 
colorimetric commercial enzyme-linked immunosorbent assay 
(ELISA) kit (R&D Systems, Minneapolis, MN) according to the 
manufacturer’s instructions and expressed as pg per ml.
Chemotaxis Assay
Chemotaxis was evaluated on cells obtained from pleural lavage 
fluids collected 4 h after carrageenan injection in a 48-well modified 
Boyden chamber (AP48, Neuro Probe, USA). Briefly, 2.50 × 105 
cells in Roswell Park Memorial Institute (RPMI-1640) medium 
containing 0.1% bovine serum albumin (BSA) (50 µl) were placed 
on top of the polycarbonate filter (8-µm pore size, Neuro Probe, 
USA) whereas 25 μl of chemoattractant N-formyl-L-methionyl-
L-leucyl-L-phenylalanine (fMLP, 1 ng/ml in RPMI-1640 medium 
containing 0.1% BSA) were added to the wells on the bottom. 
Spontaneous migration was determined using RPMI-1640 
medium without fMLP. Each condition was set up in triplicate. 
Chambers were incubated for 90 min at 37°C in humidified air 
containing 5% CO2. Following incubation, the chamber was 
disassembled and the filter was carefully removed and washed 
with sterile PBS. Cells that failed to migrate through the filter were 
wiped off the top surface of the filter. Migrated cells on the filter 
were fixed and stained with 4’,6-diamidino-2-phenylindole (DAPI, 
Vector Laboratories, Burlingame, ON, Canada), and migration 
was quantified as the total pixel count of DAPI-stained nuclei 
under the fluorescence microscope using Fiji software. Migration 
index of cells obtained from pleural lavage fluids, harvested from 
vehicle- and APCP-treated rats, was expressed as ratio between the 
number of migrated cells in presence of fMLP and the number of 
migrated cells in the absence of fMLP.
Flow Cytometry
Pleural lavage fluids recovered from the pleural cavity were 
washed twice in saline, and the resulting suspensions were 
pelleted by centrifugation at 180 × g for 10 min at 4°C. To block 
non-specific Fc-mediated interactions, cell samples were pre-
incubated with an FcR blocking reagent (BD Biosciences) on 
ice for 10 min and then incubated with the following antibodies 
against: CD11b/c-PerCP/Cy5.5 (clone OX-42, BioLegend), 
RP-1-PE (BD Pharmingen), CD68-FITC (clone ED1, GeneTex), 
and CD73-Alexa Fluor 647 (Bioss Antibodies) for 20 min in the 
dark. Data were acquired with a FACSCalibur flow cytometer 
and analyzed with CellQuest software (BD FACSCalibur, 
Milan, Italy).
Statistical Analysis
All data are presented as mean ± standard error (SE); statistical 
analysis was performed on raw data by two tailed Student’s t-test 
for unpaired data or by one-way ANOVA followed by Bonferroni 
post-hoc test as appropriate. A p value < 0.05 was considered 
statistically significant.
RESULTS
APCP Treatment Increases Pleural 
Effusion and Cell Infiltration
Treatment of rats with CD73 inhibitor, APCP (400 μg/rat), 
significantly increased cell accumulation into the pleural 
cavity 4 h following carrageenan injection compared to vehicle 
(Figure 1A), while the leukocyte number into the pleural lavage 
fluids collected at 72 h after carrageenan injection was similar 
in APCP- and vehicle-treated rats (Figure 1A). The volume of 
exudate collected by pleural lavage 4 h following carrageenan 
injection significantly increased in APCP-treated rats compared 
with control (vehicle-treated) rats (Figure 1B). There was 
no difference in the volume of exudate produced at 72 h after 
carrageenan injection between APCP- and vehicle-treated rats 
(Figure 1B).
APCP Treatment Increases Lung Damage
Morphological analysis of inflamed lung sections showed cell 
infiltration into bronchial and perivascular space as well as lung 
injury (Figure 2). The increased inflammatory cell infiltration 
in APCP-treated rats was associated with damaged lung 
architecture 4 and 72 h following carrageenan-induced pleurisy 
(Figure 2).
APCP Treatment Is Associated With 
Reduced AMPase Activity
In APCP-treated rats, the AMPase activity in cell lysates, in lung 
homogenates, and in cell-free pleural lavage fluids 4 h following 
carrageenan injection was significantly reduced compared with 
vehicle, but not at 72 h (Figures 3A, B, and C, respectively). It is 
worth noting that the AMPase activity in cell lysates at 72 h was 
higher than at 4 h (Figure 3A) and in cell-free pleural lavage fluids 
was lower at 72 h than at 4 h (Figure 3C). In lung homogenates, 
there was no difference in AMPase activity between 4 and 72 h 
(Figure 3B).
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APCP Treatment Increases Cytokine 
Production in Pleural Fluids
Following treatment with APCP, there was a significant increase 
in TNF-α, IL-6, IL-1β, and MCP-1 levels evaluated in cell-free 
pleural lavage fluids collected 4 h following pleurisy induction 
(Figures 4A, B, C, and D, respectively). In contrast, TNF-α, 
IL-6, and IL-1β levels in pleural lavage fluids collected at 72 h 
were similar in APCP- and vehicle-treated rats (Figures 4A, B, 
and C, respectively), while MCP-1 levels were still significantly 
increased in APCP-treated rats compared with control (vehicle-
treated) at 72 h (Figure 4D).
APCP Treatment Increases PMN  
Migration Index
Cells obtained from pleural lavage fluids collected from 
APCP-treated group of rats 4 h after carrageenan injection 
showed increased ability to migrate in vitro both in presence 
and in absence of a chemotactic stimulus (fMLP), compared 
to cells from vehicle groups, as showed in the representative 
images of Figure 5A. Accordingly, the migration index was 
significantly increased in samples from APCP-treated rats 
compared with control (vehicle-treated rats) in presence of 
fMLP (Figure 5B).
FIGURE 1 | Effect of APCP on leukocyte infiltration and pleural lavage fluid volume 4 and 72 h following carrageenan-induced rat pleurisy. (A) Total leukocytes.  
(B) Pleural lavage fluid volume. Data are expressed as mean ± SE, N = 10; (A) ***p < 0.001 and °°°p < 0.001 versus vehicle 4 h. (B) ***p < 0.001 versus vehicle 4 h. 
Two-tailed Student’s t-test.
FIGURE 2 | Effect of APCP on lung injury 4 and 72 h following carrageenan-induced pleurisy. Representative morphological analysis of hematoxylin and eosin 
(H&E)-stained lung sections from vehicle group (4 and 72 h) and APCP group (4 and 72 h). Black arrows indicate points of intense inflammatory cell infiltration. 
Original magnification X 20. Scale bar = 100 µm.
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FIGURE 3 | AMPase activity in cells (A), lungs (B), and pleural lavage fluids (C) collected 4 and 72 h following carrageenan-induced pleurisy. Data are expressed as 
mean ± SE, N = 6; (A) *p < 0.05 and °p < 0.05 versus vehicle 4 h. (B) **p < 0.01 versus vehicle 4 h. (C) *p < 0.05 and °°p < 0.01 versus vehicle 4 h. Bonferroni’s 
multiple comparison test.
FIGURE 4 | Effect of APCP on levels of TNF-α (A), IL-6 (B), IL-1β (C), and MCP-1 (D) in pleural lavage fluid recovered from the pleural cavity 4 and 72 h following 
carrageenan-induced rat pleurisy. Data are expressed as mean ± SE, N = 6; (A) *p< 0.05 versus vehicle 4 h. (B) *p< 0.05 versus vehicle 4 h. (C) ***p < 0.001 versus 
vehicle 4 h. (D) *p < 0.05 and °°°p < 0.001 versus vehicle 4 h; #p < 0.05 versus vehicle 72 h. Two-tailed Student’s t-test.
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Leukocyte Populations into the Pleural 
Cavity
Differential cell count of leukocytes migrated into the pleural 
cavity showed that PMN neutrophils dominated the early phase 
(4 h) of the reaction and were replaced by monocytes at 72 h (data 
not shown). To assay neutrophil and monocyte cell subsets and 
the expression of CD73, cells collected from pleural lavage fluids 
at 4 and 72 h following pleurisy induction were analyzed by ﬂow 
cytometry. Cells collected at 4 hours were mostly neutrophils 
(CD11b/c+RP-1+ cells) with no difference from APCP- and 
vehicle-treated group (Figure 6A). Moreover, the percentage 
of CD73+ cells among them (CD11b/c+RP-1+ CD73+) was very 
low in both groups (Figure 6A). Flow cytometric analysis of 
cells collected at 72 h showed that the main population within 
leucocytes were represented by monocytes/macrophages 
(CD11b/c+CD68+ cells) that were significantly reduced in pleural 
fluids harvested from APCP-treated rats compared with those 
from vehicle-treated rats (Figure 6B). In both vehicle- and 
APCP-treated groups, these cells were positive to CD73 (CD11b/
c+CD68+CD73+cells) (Figure 6B). It is worth noting that another 
subset of cells, CD11b/c+CD68-, represented about 40% of cells 
harvested at 72 h.
DISCUSSION
There is much evidence for the role of CD73 in maintenance 
the integrity of epithelial barrier (Narravula et al., 2000; Salmi 
and Jalkanen, 2005; Bowser and Broaddus, 2016). Early papers 
investigating the involvement of CD73 in physiopathological 
conditions found that this enzyme was an innate protection 
in lung injury (Eckle et al., 2007). Pleural mesothelium is a 
monolayer of mesothelial cells lining the pleural cavity, presenting 
intermediate features between epithelium and endothelium; 
mesothelial cells participate to the pleural space homeostasis and 
represent the primary cells that initiate the response to an injury 
(Mutsaers, 2004; Batra and Antony, 2015).
Injection of carrageenan into the rat pleural cavity elicits an 
inflammatory response characterized by pleural effusion that 
dominates the early phase (4 h), characterized by cell recruitment, 
mostly PMNs, cytokine production, and tissue morphological 
changes. The model may resemble human pleural effusion, a 
severe complication often associated to pulmonary and extra 
pulmonary pathologies (Vinegar et al., 1982; De Brito, 1989; 
Murai et al., 2003; Lansley et al., 2017). Here, we have evaluated 
the effect of APCP, a CD73 inhibitor, in the inflammatory 
response triggered by carrageenan, in the model of rat pleurisy.
Following rat treatment with APCP, we found increased 
pleural effusion and total cell accumulation into the pleural 
cavity, in response to carrageenan injection, 4 h thereafter. At the 
same time point, the increased cell infiltration was paralleled by 
increased cytokine levels (IL-6, TNF alpha, IL-1 beta, MCP-1) 
into the pleural cavity. Conversely, in the pleural lavage fluids 
collected 72 h following injection of carrageenan, cytokine levels 
were almost absent in agreement with evidence of their early 
involvement in this model of inflammation (Goodman et  al., 
1993; Murai et al., 2003). Furthermore, at 72 h, there was no 
difference in cellular and cytokine content between vehicle- and 
APCP-treated group, apart from MCP-1 whose levels in APCP 
group were still higher than those in vehicle group.
It is known that MCP-1 represents a chemokine that, in the 
pleural space, is produced by mesothelial and inflammatory 
FIGURE 5 | Effect of APCP on chemotaxis of leukocytes collected 4 h after carrageenan injection. (A) Representative immunofluorescence showing DAPI-stained 
nuclei from vehicle and APCP-treated group; cell chemotaxis was evaluated in presence and in absence of fMLP (see text for details). Original magnification X 10. 
(B) Histogram representing the results of migration index expressed as ratio between the number of migrated cells in presence of fMLP and the number of migrated 
cells without fMLP. Cells were collected from pleural lavage fluids harvested from vehicle- and APCP-treated rats. Data are expressed as mean ± SE, N = 8. ***p < 
0.001 versus vehicle. Two-tailed Student’s t-test.
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cells (Deshmane et al., 2009; Batra and Antony, 2015). Recently, 
Lansley et al. (2017) have demonstrated that MCP-1 plays a 
crucial role in pleural effusion in a mouse model of carrageenan-
induced pleurisy. Here, we show that MCP-1 is the cytokine 
that prevails in pleural lavage fluids at 4 and 72 h following 
carrageenan injection in rats; moreover, our results suggest that 
MCP-1 production is under the control of CD73. The role of CD73 
in the control of neutrophil influx in response to inflammation 
and infections has also demonstrated in experiments performed 
in transgenic mice lacking CD73 enzyme, in which following 
Mycobacterium tubercolosis infection, an increased influx of 
PMNs but not of monocytes has been observed (Petit-Jentreau 
et al., 2015). Consistently, we found that treatment with APCP 
at the onset of inflammation affects the early phase (4 h), 
dominated by neutrophil influx, but not the sub-acute phase 
(72 h) of inflammation, dominated by monocyte influx. APCP is 
a well described CD73 inhibitor; however, there is evidence that 
this compound also inhibits human nucleotide pyrophosphatase/
phosphodiesterases (NPPs), a related nucleotidase hydrolizing 
ATP or ADP to AMP although with very low potency (Bhattarai 
et al., 2015). NPP is also involved in the adenosine pathway 
recognized as non-canonical, leading to adenosine accumulation 
from ATP and NAD (Ferrero et al., 2019). Furthermore, there 
is evidence that APCP through increasing AMP levels may 
indirectly inhibit NTPDase (CD39) (Covarrubias et al., 2016). 
Nonetheless, what we have found is that treatment with APCP 
exacerbates carrageenan-induced pleurisy in rats; we claim that 
to this effect contributes the inhibition of CD73, and probably 
of the other enzymes involved in the adenosinergic pathway, 
with the resulting loss of the control that these ectoenzymes 
exert on the inflammatory environment. Thus, CD73, or more 
extensively the adenosinergic pathway, results to be critical for 
PMN trafficking in the model of carrageenan-induced pleurisy in 
rat. Similarly, it has been demonstrated that CD73 controls PMN 
trafficking in lung injury induced by bacterial lipopolysaccharide 
inhalation in mice (Reutershan et al., 2009).
We also attempted to analyze cells collected at 4 h, to evaluate 
how they behaved far from the inflammatory microenvironment. 
FIGURE 6 | Analysis of CD73 expression on leukocyte subpopulations recovered from the pleural cavity at 4 h (A) and 72 h (B) after carrageenan injection. Flow 
cytometry dot plots in panel A (left) show a representative experiment illustrating the gating strategy used to analyze CD11b/c positive (+) RP-1 positive (+) cells gated 
on leukocytes population identified by forward and side scatter characteristics. The CD73 expression was analyzed on CD11b/c+ RP-1+ cells. On the right of panel 
A, histograms summarize the percentage of cells positive to CD11b/c and RP-1 and the percentage of CD73 positive cells among CD11b/c+ RP-1+ cells in vehicle 
and APCP groups. Data are expressed as mean ± SE, N = 7. In panel B, flow cytometry dot plots are representative of CD11b/c+ CD68+ cells within leukocyte 
population identified by forward and side scatter characteristics. CD11b/c+ CD68+ cells were then analyzed for their CD73 expression. On the right of panel B, 
histograms summarize the percentage of cells positive to CD11b/c and CD68 and the percentage of CD73 positive cells among CD11b/c+ CD68+ cells in vehicle 
and APCP groups. Results represent mean ± SE, N = 7. **p < 0.01. Two-tailed Student’s t-test.
CD73 Inhibition in Rat PleurisyCaiazzo et al.
8 July 2019 | Volume 10 | Article 775Frontiers in Pharmacology | www.frontiersin.org
For this purpose, we evaluated cell migration ex vivo, in presence 
or not of fMLP as chemoattractant agent. Interestingly, we 
found that PMNs collected from APCP-treated animals showed 
increased ability to migrate, even spontaneously, in absence of 
fMLP, compared to cells obtained from vehicle group. These 
results suggest that early inhibition of CD73 makes inflammatory 
cells, mostly neutrophils, prone to migrating. Likely, this effect 
may depend upon a contact with elevated levels of cytokines 
of cells obtained from APCP-treated animals compared to cells 
obtained from inflamed vehicle-treated animals. Alternatively, we 
might hypothesize that when CD73 is inhibited, a phenotypically 
different neutrophil population accumulates at the site of 
inflammation.
Neutrophil heterogeneity has been described (Scapini 
et  al., 2016), and it is known that their differentiation toward 
distinct subpopulations depends upon environmental signals 
and also their lifespan (Silvestre-Roig et al., 2016). It is known 
that CD73 expression on neutrophils is normally low, and it’s 
under the control of inflammatory cytokines (Szabo and Pacher, 
2012; Antonioli et al., 2013). By performing flow cytometric 
analysis of cells accumulated into the pleural space, we found 
that only a very small percentage of all leukocytes accumulated 
4 h following carrageenan injections were CD73+, conversely, 
almost the totality of leukocytes accumulated at 72 h were 
CD73+, and there was no difference in the percentage of cells 
CD73+ between vehicle- and APCP-treated group. Nonetheless, 
there was difference in AMPase activity between cells obtained 
from the two groups, being the activity of cells recovered from 
pleural lavage fluid of APCP-treated rats significantly lower than 
AMPase activity of cells from vehicle-treated group. All together, 
these results suggest that cell trafficking into the pleural space 
is regulated by CD73 enzymatic activity. Our data agree with 
previous experimental results, in mice, and clinical data that 
highlight the important regulatory role of CD73 in the control 
of cell trafficking and cytokine production in an inflammatory 
environment (Reutershan et al., 2009; Petrovic-Djergovic et al., 
2012; Al-Taei et al., 2016).
However, to better understand the mechanism by which 
CD73/adenosine pathway controls the inflammatory reaction in 
our model, we need to establish which cells are targeted by APCP. 
Indeed, we found that the effect of rat treatment with APCP was 
evident at 4 hours, when only a very small subset of infiltrating 
cells were CD73+; thus, it is conceivable that APCP does not 
exert its effect on recruited cells but on stromal cells and/or on 
other type of cells, such as dendritic cells, representing a first line 
of host defense and demonstrating to infiltrate the pleural space 
(Condon et al., 2011). It is known that dendritic cells expressing 
both CD39 and CD73 transform a proinflammatory ATP-rich 
microenvironment into an antinflammatory adenosine rich 
environment (Silva-Vilches et al., 2018). Unfortunately, we did 
not sort dendritic cells by flow cytometry; nonetheless, it can be 
argued that subset of cells CD11b/c+CD68- found at 72 hours are 
dendritic cells; however, this point needs to be further investigated.
In conclusion, rat treatment with APCP exacerbates the 
early phase of inflammation by controlling pleural effusion and 
polymorphonuclear migration in vivo and ex vivo. Although 
we cannot rule out the possibility that APCP inhibits other 
ectoenzymes involved in the adenosinergic pathway, we argue 
that CD73 inhibition might play a major role. On this basis, we 
suggest that CD73 might represent a valid biomarker for pleural 
effusion besides being a potential target for novel therapeutic 
interventions.
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